NSF Supercomputer Program Looks Beyond Princeton Recall

The National Science Foundation’s cancellation of funding for the John von Neumann National Supercomputer Center has, as might be expected, drawn sharp criticism from supporters of the Princeton, N.J., facility. But here, the move is being watched as a leading indicator of where the program is headed. Assuming the failure of a lastditch effort by the Princeton center to reverse NSF’s rejection of its request for $70 million over the next five years, NSF officials say that the e

Written byChristopher Anderson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The National Science Foundation’s cancellation of funding for the John von Neumann National Supercomputer Center has, as might be expected, drawn sharp criticism from supporters of the Princeton, N.J., facility. But here, the move is being watched as a leading indicator of where the program is headed.

Assuming the failure of a lastditch effort by the Princeton center to reverse NSF’s rejection of its request for $70 million over the next five years, NSF officials say that the equivalent amount of money could be put to several conceivable uses. Possibilities include, expansion of four remaining centers in the agency’s four-year-old supercomputing program, support for state-sponsored supercomputing centers, or the creation of a new center, possibly based on massively parallel supercomputers such as the revolutionary 65,000-processor Connection Machine.

While the agency looks forward, officials at the Von Neumann center are scrambling to survive. The center’s problems stem largely from the fact ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies